Cleveland BioLabs Inc. (NASDAQ:CBLI) shares rose 5.5% during trading on Monday . The company traded as high as $2.68 and last traded at $2.51, with a volume of 68,283 shares trading hands. The stock had previously closed at $2.38.

The firm’s market cap is $27.58 million. The stock has a 50-day moving average of $2.64 and a 200-day moving average of $2.74.

Cleveland BioLabs (NASDAQ:CBLI) last posted its earnings results on Monday, May 16th. The company reported ($0.06) earnings per share for the quarter. Equities research analysts forecast that Cleveland BioLabs Inc. will post ($0.16) EPS for the current year.

Cleveland BioLabs, Inc (CBLI) is a biopharmaceutical company. The Company’s programs are focused developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.